City

Seoul (2)

Condition

Healed Erosive Esophagitis (2)

Overall Status

Unknown status (2)

Sign in for free

Phase

phase 3 (2)

Sponsor

Daewoong Pharmaceutical Co. LTD. (1)

HK inno.N Corporation (1)

Collaborator

Intervention

dwp14012 20 mg (1)

dwp14012 20 mg placebo (1)

lansoprazole 15 mg (1)

lansoprazole 15 mg placebo (1)

lansoprazole 15mg qd (1)

tegoprazan 25mg qd (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

healed erosive esophagitis

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Healed Erosive Esophagitis Trial in Seoul (DWP14012 20 mg, DWP14012 20 mg , Lansoprazole 15 mg)

Unknown status

Healed Erosive Esophagitis

DWP14012 20 mg
+3 more

Seoul, Korea, Republic of

The Catholic University of Korea, Yeouido ST. Mary's Hospital

Sep 1, 2020

Healed Erosive Esophagitis Trial in Seoul (Tegoprazan 25mg QD, Lansoprazole 15mg QD)

Unknown status

Healed Erosive Esophagitis

Tegoprazan 25mg QD
Lansoprazole 15mg QD

Seoul, Korea, Republic of

Hanyang University Seoul Hospital

Jul 14, 2019